Načítá se...
Pre-treatment prediction of response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis: the UDCA Response Score
BACKGROUND: Current guidelines advocate a step-wise approach to disease-modifying treatment of primary biliary cholangitis (PBC): all patients begin treatment with ursodeoxycholic acid (UDCA) monotherapy – and those with inadequate biochemical response to UDCA are subsequently considered for second-...
Uloženo v:
| Vydáno v: | Lancet Gastroenterol Hepatol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6962055/ https://ncbi.nlm.nih.gov/pubmed/30017646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(18)30163-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|